Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Other Operating Expenses of $25.8 million for Q1 2026, down 14.92% year-over-year from $30.3 million in Q1 2025, and down 91.98% quarter-over-quarter from $321.4 million in Q4 2025.
Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $25.8 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 14.92% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $413.7 million (up 694.03% YoY), while the FY2025 annual figure was $148.7 million, up 164.92% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $25.8 million, down from $321.4 million in the prior quarter.
- The five-year high for Other Operating Expenses was $321.4 million in Q4 2025, with the low at -$62.9 million in Q2 2024.
- The 4-year median for Other Operating Expenses is $29.4 million (2025), against an average of $50.1 million.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 82.78% in 2024, then jumped 1653.09% in 2025.
- Organogenesis Holdings' Other Operating Expenses stood at $106.5 million in 2023, then slumped by 82.78% to $18.3 million in 2024, then surged by 1653.09% to $321.4 million in 2025, then plunged by 91.98% to $25.8 million in 2026.
- Business Quant data shows ORGO's Other Operating Expenses at $25.8 million in Q1 2026, $321.4 million in Q4 2025, and $37.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 242.55 Mn | 195.71 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.49 Mn |
| Mar 31, 2026 | 25.77 Mn |
| Dec 31, 2025 | 321.41 Mn |
| Sep 30, 2025 | 37.17 Mn |
| Jun 30, 2025 | 29.38 Mn |
| Mar 31, 2025 | 30.29 Mn |
| Dec 31, 2024 | 18.33 Mn |
| Sep 30, 2024 | -55.34 Mn |
| Jun 30, 2024 | -62.93 Mn |
| Dec 31, 2023 | 106.48 Mn |
| Jun 30, 2018 | 3.49 Mn |
| Dec 31, 2017 | -37.82 Mn |
| Sep 30, 2017 | -35.13 Mn |
| Jun 30, 2017 | -35.95 Mn |
| Mar 31, 2017 | -29.28 Mn |
| Dec 31, 2016 | 178,156.00 |
| Sep 30, 2016 | 14,492.00 |
| Mar 31, 2016 | 15,550.00 |